Cleveland Clinic And IBM Unveil Landmark 10-Year Partnership To Accelerate Discovery In Healthcare And Life Sciences
IBM News, March 30th, 2021
March 30, 2021,
Volume 276, Issue 5
IBM Hybrid Cloud, High Performance Computing, Artificial Intelligence, and Quantum Computing technologies to serve as foundation for newly launched Cleveland Clinic Global Center for Pathogen Research & Human Health
Cleveland Clinic and IBM (NYSE: IBM) have announced a planned 10-year partnership to establish the Discovery Accelerator, a joint Cleveland Clinic - IBM center with the mission of fundamentally advancing the pace of discovery in healthcare and life sciences through the use of high performance computing on the hybrid cloud, artificial intelligence (AI) and quantum computing technologies.
The collaboration is anticipated to build a robust research and clinical infrastructure to empower big data medical research in ethical, privacy preserving ways, discoveries for patient care and novel approaches to public health threats such as the COVID-19 pandemic. Through the Discovery Accelerator, the researchers plan to use advanced computational technology to generate and analyze data to help enhance research in the new Global Center for Pathogen Research & Human Health, in areas such as: genomics, single cell transcriptomics, population health, clinical applications, and chemical and drug discovery.
Read More ...